Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine

Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapineCost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine, Published online: 03 January 2018; doi:10.1038/s41397-017-0004-2Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine

https://www.nature.com/articles/s41397-017-0004-2

Source: The Pharmacogenomics Journal - January 3, 2018 Category: Drugs & Pharmacology Authors: Fran çois R. Girardin Antoine Poncet Arnaud Perrier Nathalie Vernaz Mark Pletscher Caroline F. Samer Jeffrey A. Lieberman Jean Villard Source Type: research

More News: Drugs & Pharmacology